Designates third full week of May of each year as "Clinical Trials Awareness Week" and May 20 of each year as "Clinical Trials Volunteers Appreciation Day" in NJ.
Impact
This resolution underscores the significance of clinical trials in the medical community, addressing their necessity in the development of successful treatments for various diseases. It seeks to engrain the awareness of clinical trials within public consciousness, thus potentially increasing volunteer participation in future studies. By creating designated days for recognition, the bill aims to enhance public engagement and appreciation for the role of clinical trials in medical advancements.
Summary
AJR117 is a joint resolution introduced in New Jersey that designates the third full week of May as 'Clinical Trials Awareness Week' and May 20 as 'Clinical Trials Volunteers Appreciation Day'. The resolution emphasizes the importance of clinical trials in advancing medical research and highlights their role in discovering new treatments and understanding diseases. This legislative initiative aims to promote awareness about the contributions of clinical trials to public health and to recognize the vital participation of volunteers.
Contention
While there is a broad bipartisan agreement on the value of clinical trials, some concerns may arise regarding the accessibility of information to the public and the representation of diverse populations in clinical research. Ensuring that clinical trials are inclusive and equitable remains a significant conversation point. Moreover, while the resolution promotes awareness, the effectiveness of such proclamations in driving real change and participation may also be scrutinized.
Carry Over
Designates third full week of May of each year as "Clinical Trials Awareness Week" and May 20 of each year as "Clinical Trials Volunteers Appreciation Day" in NJ.